You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization, look for clinical trials, and connect with others living with it — all in one place.
Open the full Congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization hub →Congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization is a rare condition. Also known as Alloimmune neonatal renal disease, FMAIG, Fetomaternal alloimmunization with antenatal glomerulopathies, Neonatal glomerulopathy due to neprilysin alloimmunization, Neonatal membranous glomerulopathy with maternal NEP deficiency, Neonatal membranous glomerulopathy with maternal neutral endopeptidase deficiency. Tomeko brings together the specialists, research, clinical trials, treatments and community for Congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:69063 · ICD-10 P96.0 · GARD 0018896
Start by learning the basics from an authoritative source, find a specialist or center that sees Congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization, filtered to your area.
Tomeko shows live, recruiting studies for Congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization from ClinicalTrials.gov on the hub.